REGENXBIO Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

REGENXBIO Inc. reported Cash And Cash Equivalents At Carrying Value of $34.47 million for the year ending 2025.

  • REGENXBIO Inc. showed a decrease of -40.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), REGENXBIO Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,491.2%.
  • Historical annual values: Fiscal year 2025: $34.47 million | Fiscal year 2024: $57.53 million | Fiscal year 2023: $34.52 million | Fiscal year 2022: $96.95 million | Fiscal year 2021: $345.21 million | Fiscal year 2020: $338.43 million | Fiscal year 2019: $69.51 million | Fiscal year 2018: $75.56 million | Fiscal year 2017: $46.66 million | Fiscal year 2016: $24.84 million | Fiscal year 2015: $54.12 million | Fiscal year 2014: $1.12 million | Fiscal year 2013: $1.12 million | Fiscal year 2012: $2.17 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: